Mansa

Mansa Bioworks is a biotechnology company developing a next-generation platform for high-throughput single-cell proteomics. The company's technology aims to bridge the gap between genomics and functional biology by enabling the measurement of thousands of proteins within individual cells. Founded by a team of experts from 10x Genomics, Mansa Bioworks utilizes advanced microfluidics and molecular barcoding to achieve unprecedented scale in protein analysis. Their platform is designed to provide researchers with a more comprehensive understanding of cellular states, which is critical for drug discovery and biomarker identification. By uncovering the functional proteomic landscape, the company seeks to accelerate the development of precision medicines across various therapeutic areas, including oncology and immunology.